244 related articles for article (PubMed ID: 24007143)
1. Experimentally studied dynamic dose interplay does not meaningfully affect target dose in VMAT SBRT lung treatments.
Stambaugh C; Nelms BE; Dilling T; Stevens C; Latifi K; Zhang G; Moros E; Feygelman V
Med Phys; 2013 Sep; 40(9):091710. PubMed ID: 24007143
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
3. Simulation of dosimetry impact of 4DCT uncertainty in 4D dose calculation for lung SBRT.
Liu G; Hu F; Ding X; Li X; Shao Q; Wang Y; Yang J; Quan H
Radiat Oncol; 2019 Jan; 14(1):1. PubMed ID: 30621744
[TBL] [Abstract][Full Text] [Related]
4. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments.
Ehrbar S; Lang S; Stieb S; Riesterer O; Stark LS; Guckenberger M; Klöck S
Z Med Phys; 2016 Mar; 26(1):45-53. PubMed ID: 26187810
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric impact of the interplay effect during stereotactic lung radiation therapy delivery using flattening filter-free beams and volumetric modulated arc therapy.
Ong CL; Dahele M; Slotman BJ; Verbakel WF
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):743-8. PubMed ID: 23773394
[TBL] [Abstract][Full Text] [Related]
7. Comparing phase- and amplitude-gated volumetric modulated arc therapy for stereotactic body radiation therapy using 3D printed lung phantom.
Lee M; Yoon K; Cho B; Kim SS; Song SY; Choi EK; Ahn S; Lee SW; Kwak J
J Appl Clin Med Phys; 2019 Feb; 20(2):107-113. PubMed ID: 30667581
[TBL] [Abstract][Full Text] [Related]
8. Comparison of planned dose on different CT image sets to four-dimensional Monte Carlo dose recalculation using the patient's actual breathing trace for lung stereotactic body radiation therapy.
Freislederer P; von Münchow A; Kamp F; Heinz C; Gerum S; Corradini S; Söhn M; Reiner M; Roeder F; Floca R; Alber M; Belka C; Parodi K
Med Phys; 2019 Jul; 46(7):3268-3277. PubMed ID: 31074510
[TBL] [Abstract][Full Text] [Related]
9. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung.
Chin E; Loewen SK; Nichol A; Otto K
Phys Med Biol; 2013 Feb; 58(4):749-70. PubMed ID: 23324560
[TBL] [Abstract][Full Text] [Related]
10. 3D delivered dose assessment using a 4DCT-based motion model.
Cai W; Hurwitz MH; Williams CL; Dhou S; Berbeco RI; Seco J; Mishra P; Lewis JH
Med Phys; 2015 Jun; 42(6):2897-907. PubMed ID: 26127043
[TBL] [Abstract][Full Text] [Related]
11. Dynamic simulation of motion effects in IMAT lung SBRT.
Zou W; Yin L; Shen J; Corradetti MN; Kirk M; Munbodh R; Fang P; Jabbour SK; Simone CB; Yue NJ; Rengan R; Teo BK
Radiat Oncol; 2014 Nov; 9():225. PubMed ID: 25365935
[TBL] [Abstract][Full Text] [Related]
12. Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in Stereotactic Lung Radiation Therapy.
Purdie TG; Moseley DJ; Bissonnette JP; Sharpe MB; Franks K; Bezjak A; Jaffray DA
Acta Oncol; 2006; 45(7):915-22. PubMed ID: 16982558
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric evaluation of the interplay effect in respiratory-gated RapidArc radiation therapy.
Riley C; Yang Y; Li T; Zhang Y; Heron DE; Huq MS
Med Phys; 2014 Jan; 41(1):011715. PubMed ID: 24387507
[TBL] [Abstract][Full Text] [Related]
14. Forcing lateral electron disequilibrium to spare lung tissue: a novel technique for stereotactic body radiation therapy of lung cancer.
Disher B; Hajdok G; Gaede S; Mulligan M; Battista JJ
Phys Med Biol; 2013 Oct; 58(19):6641-62. PubMed ID: 24018569
[TBL] [Abstract][Full Text] [Related]
15. On the validity of density overrides for VMAT lung SBRT planning.
Wiant D; Vanderstraeten C; Maurer J; Pursley J; Terrell J; Sintay BJ
Med Phys; 2014 Aug; 41(8):081707. PubMed ID: 25086517
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of delivered dose to a moving target by 4D dose reconstruction in gated volumetric modulated arc therapy.
Chung H; Jung J; Jeong C; Kwak J; Park JH; Kim SS; Yoon SM; Song SY; Kim JH; Choi EK; Cho S; Cho B
PLoS One; 2018; 13(9):e0202765. PubMed ID: 30192793
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison of four-dimensional computed tomography based internal target volume against variations in respiratory motion during treatment between volumetric modulated arc therapy and three-dimensional conformal radiotherapy in lung stereotactic body radiotherapy.
Fujimoto D; Takatsu J; Hara N; Oshima M; Tomihara J; Segawa E; Inoue T; Shikama N
Radiol Phys Technol; 2024 Mar; 17(1):143-152. PubMed ID: 37930563
[TBL] [Abstract][Full Text] [Related]
18. VMAT-SBRT planning based on an average intensity projection for lung tumors located in close proximity to the diaphragm: a phantom and clinical validity study.
Ohira S; Ueda Y; Hashimoto M; Miyazaki M; Isono M; Kamikaseda H; Masaoka A; Takashina M; Koizumi M; Teshima T
J Radiat Res; 2016 Jan; 57(1):91-7. PubMed ID: 26419645
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric effect of respiratory motion on volumetric-modulated arc therapy-based lung SBRT treatment delivered by TrueBeam machine with flattening filter-free beam.
Li X; Yang Y; Li T; Fallon K; Heron DE; Huq MS
J Appl Clin Med Phys; 2013 Nov; 14(6):4370. PubMed ID: 24257279
[TBL] [Abstract][Full Text] [Related]
20. Interplay effects in highly modulated stereotactic body radiation therapy lung cases treated with volumetric modulated arc therapy.
Fernandez DJ; Sick JT; Fontenot JD
J Appl Clin Med Phys; 2020 Nov; 21(11):58-69. PubMed ID: 33104297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
